Delcath Share Price

Delcath Share Price

NASDAQ: DCTH | Small Cap | Healthcare
$18.81
-$0.42 (-2.18%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Delcath Stock Performance

Open
$19.08
Prev. Close
$19.23
Circuit Range
N/A
Day Range
$18.59 - $19.28
Year Range
$8.13 - $22.48
Volume
18,652
Average Traded
$18.86

Delcath Share Price Today

As of 21 November 2026, Delcath Systems, Inc.'s share price is $18.81. The stock opened at $19.08, compared to its previous close of $19.23. During today's trading session, Delcath Systems, Inc.'s share price traded between $18.59 and $19.28, with an average price of $18.94. Over the past 52 weeks, the stock has recorded a high of $22.48 and a low of $8.13. In terms of performance, Delcath Systems, Inc.'s share price has risen by 74.33% over the last six months and is up 93.72% on a year-on-year basis.

Delcath Share Price Chart

Line chart of the Delcath price trend over the selected period. The price fell overall, ranging from 18.58 to 19.32, ending at 18.81.
$18.59$19.28
L
Show Current Price
H

Delcath Stock Fundamentals & Key Indicators

Market Cap
$673.80M
PE Ratio (TTM)
98.24
Dividend Yield
0.00%
EPS (TTM)
$0.19
Revenue (TTM)
$85.23B
Return On Equity (TTM)
4.98%
Profit Margin
3.17%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
465.79%

Delcath Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$20.73$24.99$29.13$35.10
Net Profit-$1.90-$1.07$2.67$6.95
Net Profit Margin-9.17%-4.28%9.17%19.80%
Income ChangeN/A43.68%349.53%160.30%

Delcath Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$2.72$2.07$37.21$85.23
Net Profit-$36.51-$47.68-$26.39$2.70
Net Profit Margin-1342.28%-2303.38%-70.92%3.17%
Income ChangeN/A-30.59%44.65%110.23%

Delcath Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets4.12.831.461.71
Current Assets119.5373.7637.1616.16
Total Assets123.6376.5938.6117.86
Non Current Liabilities1.461.76.398.99
Current Liabilities10.956.1416.4514.74
Total Liabilities12.417.8422.8423.72
Shareholders' Equity111.2268.7515.78-5.86

Delcath Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating22.52-18.68-31.25-24.95
Investing-26.59-0.98-19.71-0.21
Financing15.0539.4151.7810.14

Corporate Actions

Split
Ex-date: 24 Dec 2019

About Delcath

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Delcath Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$14.14
$18.85
+34.16%
Oct 2026
$15.73
$14.05
-12.02%
Sep 2026
$16.47
$15.97
-2.50%
Aug 2026
$12.48
$16.38
+34.14%
Jul 2026
$12.61
$12.21
-3.02%
Jun 2026
$10.89
$12.59
+16.68%
May 2026
$10.61
$10.79
+3.95%
Apr 2026
$9.43
$10.38
+11.85%
Mar 2026
$8.71
$9.28
+4.33%
Feb 2026
$9.88
$8.89
-10.33%
Jan 2026
$10.05
$9.92
-1.64%
Dec 2025
$9.58
$10.09
+3.86%

Delcath Share Price FAQs